Small Molecule API 2017 Global Market Key Players –Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp.– Analysis and Forecast to 2027

Small Molecule API Market 2017

Introduction
The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period.

The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others.

The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions.

Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016.
The scope of global small molecule API market study includes the market value, market size and a detailed analysis of vendor products and strategies.

Key Players,
The leading players of the global small molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others.

Study Objectives of Small molecule API Market Development and Demand Forecast to 2027 Market
Ø To provide insights about factors, influencing and affecting the market growth
Ø To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
Ø To provide historically and forecast revenue of the market segments based on type, and sub-segment for global Small molecule API market
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Ø To provide economic factors that influence the global Small molecule API market

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027

Target Audience
• Small molecule API companies
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• On the basis of types, synthetic/chemical API accounted for the largest market share of 81.31 % in 2016.
• US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period.

The reports also cover country level analysis:
• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

Complete Report Details @ https://www.wiseguyreports.com/reports/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027

Table of Contents

1 INTRODUCTION 12
1.1 DEFINITION 12
1.2 SCOPE OF STUDY 12
1.2.1 RESEARCH OBJECTIVE 12
1.2.2 ASSUMPTIONS & LIMITATIONS 13
1.2.2.1 ASSUMPTIONS 13
1.2.2.2 LIMITATIONS 13
1.3 MARKET STRUCTURE: 13

…..

10 COMPANY PROFILE 80
10.1 ALBEMARLE CORPORATION 80
10.1.1 OVERVIEW 80
10.1.2 PRODUCT OVERVIEW 80
10.1.3 FINANCIALS 81
10.1.4 KEY DEVELOPMENTS 81
10.2 ALLERGAN PLC 82
10.2.1 OVERVIEW 82
10.2.2 PRODUCT OVERVIEW 82
10.2.3 FINANCIALS 83
10.2.4 KEY DEVELOPMENTS 83
10.3 AUROBINDO PHARMA 84
10.3.1 OVERVIEW 84
10.3.2 PRODUCT OVERVIEW 84
10.3.3 FINANCIALS 85
10.3.4 STRATEGY 85
10.3.5 KEY DEVELOPMENT 85
10.4 CAMBREX CORPORATION 86
10.4.1 OVERVIEW 86
10.4.2 PRODUCT OVERVIEW 86
10.4.3 FINANCIALS 87
10.4.4 KEY DEVELOPMENTS 87
10.5 DR. REDDY’S LABORATORIES LTD. 88
10.5.1 OVERVIEW 88
10.5.2 PRODUCT OVERVIEW 88
10.5.3 FINANCIALS 89
10.5.4 KEY DEVELOPMENTS 89
10.6 GLAXOSMITHKLINE PLC 90
10.6.1 OVERVIEW 90
10.6.2 PRODUCT OVERVIEW 90
10.6.3 FINANCIALS 91
10.6.4 STRATEGY 91
10.6.5 KEY DEVELOPMENTS 92
10.7 LONZA 92
10.7.1 OVERVIEW 92
10.7.2 PRODUCT OVERVIEW 92
10.7.3 FINANCIALS 93
10.7.4 STRATEGY 93
10.7.5 KEY DEVELOPMENTS 94
10.8 MERCK SHARP & DOHME CORP. 94
10.8.1 OVERVIEW 94
10.8.2 PRODUCT OVERVIEW 95
10.8.3 FINANCIAL 95
10.8.4 KEY DEVELOPMENTS 96
10.9 MYLAN N.V. 96
10.9.1 OVERVIEW 96
10.9.2 PRODUCT OVERVIEW 97
10.9.3 FINANCIALS 97
10.9.4 KEY DEVELOPMENTS 98
10.10 NOVARTIS AG 98
10.10.1 OVERVIEW 98
10.10.2 PRODUCT OVERVIEW 99
10.10.3 FINANCIALS 99
10.10.4 STRATEGY 99
10.10.5 DEVELOPMENTS 100
10.11 PFIZER INC. 100
10.11.1 OVERVIEW 100
10.11.2 PRODUCT OVERVIEW 101
10.11.3 FINANCIALS 101
10.11.4 KEY DEVELOPMENTS 102
10.12 SIEGFRIED AG 102
10.12.1 OVERVIEW 102
10.12.2 PRODUCT OVERVIEW 102
10.12.3 FINANCIALS 103
10.12.4 KEY DEVELOPMENTS 103
10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 104
10.13.1 OVERVIEW 104
10.13.2 PRODUCT OVERVIEW 104
10.13.3 FINANCIALS 105
10.13.4 KEY DEVELOPMENTS 105
10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 106
10.14.1 OVERVIEW 106
10.14.2 PRODUCT OVERVIEW 106
10.14.3 FINANCIALS 107
10.14.4 STRATEGY 107
10.14.5 KEY DEVELOPMENTS 108

Continued…….

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check :

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check :

https://www.wiseguyreports.com/seminars

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

ADDRESS:
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India

This release was published on openPR.